Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline for complicated intra-abdominal infections
NCT00136201Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2005
- Primary completion
- Dec 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tigecycline in Intra-abdominal infection (IAI), sponsored by Pfizer. Started Nov 2005; status: completed.
02
Drugs
tigecycline
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT00136201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136201.